Hello, everyone. Nice to see you again. Hope the weekend was relaxing. Now, of course, the routine returns as meetings and deadlines beckon. What better way to get prepared than to brew a cup of stimulation and survey the news of the world? Please join us as we indulge. Meanwhile, have a great day and stay in touch...
Data Show Declining R&D Productivity (Reuters)
Roche Diabetes Drug Continues To Disappoint (Dow Jones)
Shire Braces For FDA Study On ADHD Drugs And Heart Risks (The Guardian)
Eisai To Hire 100 People For Lab In India (Bloomberg News)
Non-reimbursable Rx Sales Outpaced French Market Growth (PharmaTimes)
Analyst Foresees Lilly Acquiring Amylin Pharma (Benzinga)
Brand-Name Drugmakers Spend Too Little On R&D In Canada (Vancouver Sun)
Vietnam Wants To Increase Access To Essential Meds (VNA)
Former UK Minister Claims Never To Have Opposed Generics (InterPressService)
Aqua Pharma Bought By Private Equity Firm (MedCity News)